Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Working Capital to Net Assets Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Working Capital to Net Assets ratio of 42.8% as of June 2025. Working capital of $1.02 Billion (current assets of $1.50 Billion minus current liabilities of $475.62 Million) is measured against net assets of $2.39 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Shanghai Shenqi Pharmaceutical Investmen to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Working Capital to Net Assets (2015–2024)
This chart shows how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 42.8%, reflecting working capital of $1.02 Billion against net assets of $2.39 Billion USD. For the complete balance sheet picture, see 900904 total assets.
Annual Working Capital to Net Assets for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Shanghai Shenqi Pharmaceutical Investmen's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 43.9% | $1.07 Billion | $2.43 Billion | $1.60 Billion | $530.88 Million | ▼ -1.6 pp |
| 2023 | 45.4% | $1.09 Billion | $2.39 Billion | $1.77 Billion | $686.04 Million | ▲ +3.5 pp |
| 2022 | 42.0% | $995.55 Million | $2.37 Billion | $1.77 Billion | $774.34 Million | ▲ +1.6 pp |
| 2021 | 40.4% | $966.05 Million | $2.39 Billion | $1.45 Billion | $479.81 Million | ▼ -1.5 pp |
| 2020 | 41.8% | $973.89 Million | $2.33 Billion | $1.43 Billion | $457.39 Million | ▼ -6.8 pp |
| 2019 | 48.7% | $1.30 Billion | $2.66 Billion | $1.88 Billion | $583.45 Million | ▲ +0.5 pp |
| 2018 | 48.2% | $1.25 Billion | $2.60 Billion | $1.74 Billion | $487.17 Million | ▼ -2.4 pp |
| 2017 | 50.6% | $1.28 Billion | $2.53 Billion | $1.83 Billion | $546.16 Million | ▼ -4.3 pp |
| 2016 | 54.9% | $1.34 Billion | $2.43 Billion | $1.88 Billion | $546.34 Million | ▲ +0.9 pp |
| 2015 | 54.0% | $1.24 Billion | $2.29 Billion | $1.59 Billion | $357.66 Million | — |